ACIU today
$2.13-$0.01 (-0.47%)close Nov 13, 2026Trend
DailyDowntrend (starting)
4 hourStrong Bearish
1 hourStrong Bullish
15 minBullish
5 minStrong Bearish
Daily trend turns up above $5.14
Key levels
Resistance$2.35
Resistance$2.19
Support$2.02
Support$1.82
Latest news & SEC filings
EarningsAC Immune posts smaller quarterly loss than expected, revenue tops forecast
All ACIU news →About AC Immune
AC Immune is a clinical-stage biopharmaceutical company that creates treatments and diagnostic tools for illnesses caused by incorrectly folded proteins, including Alzheimer's and Parkinson's, plus rare neurodegenerative disorders. Its pipeline is based on two in-house technology platforms, Morphomer and SupraAntigen, which it uses to generate drug candidates and move them through clinical testing. The company is headquartered in Switzerland and carries out research, manufacturing, and trials through partners in multiple countries.
Based on the company's 20-F filed Mar 13, 2026.
Nasdaq · Healthcare
AC Immune SA (ACIU)
What Is the Price Target for ACIU?
SEPT Low Target
$8.00
SEPT Mid Target
$8.00
SEPT High Target
$8.00
Analyst Consensus
$8.00
Is ACIU a Buy or Sell Right Now?
Thesis
- •Revenue growing -86.1% YoY with STRONG trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for ACIU.
Start Free Trial →Is ACIU Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
Analyst Consensus
Fair Value
$8.00
15
Moat Score
NONE
1/9
Piotroski Score
-4.5
Altman Z-Score
What Is Smart Money Doing with ACIU?
Insider Signal
NEUTRAL
1 buys / 2 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Twyman Roy Ervin | director | Buy | 16,568 | - | Jun 11, 2026 |
| AGUIAR-LUCANDER RENEE | director | Buy | 16,568 | - | Jun 11, 2026 |
| Zuegel Martin | director officer | Buy | 33,136 | - | Jun 11, 2026 |
| Buetler Monika | director | Buy | 17,751 | - | Jun 11, 2026 |
| June Carl Howard | director | Buy | 16,568 | - | Jun 11, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →ACIU Growth Story
Revenue YoY
-86.1%
3yr Revenue CAGR
1.4%
EPS Growth YoY
-45.58%
FCF Growth YoY
-214.0%
Revenue Trend
STRONG
Dark Pool Trades for ACIU
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for ACIU, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 17:14:18 | $2.10 | 1,300 | $$3K | SELL |
| 16:09:05 | $2.08 | 1,500 | $$3K | BUY |
| 15:25:49 | $2.09 | 2,000 | $$4K | BUY |
| 15:14:24 | $2.09 | 9,002 | $$19K | BUY |
| 14:57:46 | $2.10 | 1,000 | $$2K | BUY |
5 dark pool trades shown · $$31K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for AC Immune SA (ACIU) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (0 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →ACIU — frequently asked questions
What is ACIU stock price today?
AC Immune SA (ACIU) is at $2.13, down 0.47% (-$0.01) at the Nov 13, 2026 close.
Why is ACIU stock moving today?
Latest ACIU news — Nov 4, 2026: AC Immune posts smaller quarterly loss than expected, revenue tops forecast
What is the ACIU price target?
The average analyst price target for ACIU is $8.00, ranging from $8 to $8, based on 1 analysts.
What do analysts rate ACIU?
Analyst ratings for ACIU: 0 Buy, 3 Hold, 0 Sell — consensus Hold.
Did ACIU beat earnings?
ACIU last reported on Aug 5, 2026: EPS $0.03 vs -$0.10 expected — a beat of 128.7%.
Does ACIU pay a dividend?
ACIU does not currently pay a dividend.
What are ACIU support and resistance levels?
Support: $2.02, $1.82, $1.65. Resistance: $2.19, $2.35, $2.55.
What are insiders doing with ACIU?
Insider activity: NEUTRAL, 1 buys and 2 sells in the last 90 days.
What is the latest news on ACIU?
Nov 4, 2026: AC Immune posts smaller quarterly loss than expected, revenue tops forecast